نتایج جستجو برای: temperature fixed at 15oc vaccine titers

تعداد نتایج: 4164500  

Journal: :The New England journal of medicine 2009
Michael E Greenberg Michael H Lai Gunter F Hartel Christine H Wichems Charmaine Gittleson Jillian Bennet Gail Dawson Wilson Hu Connie Leggio Diane Washington Russell L Basser

BACKGROUND A novel 2009 influenza A (H1N1) virus is responsible for the first influenza pandemic in 41 years. A safe and effective vaccine is needed. A randomized, observer-blind, parallel-group trial evaluating two doses of an inactivated, split-virus 2009 H1N1 vaccine in healthy adults between the ages of 18 and 64 years is ongoing at a single site in Australia. METHODS We evaluated the imm...

2017
Sandra Fuentes Laura Klenow Hana Golding Surender Khurana

In current study, we evaluated the safety and protective efficacy of recombinant unglycosylated RSV G protein ectodomain produced in E. coli (in presence and absence of oil-in-water adjuvant) in a preclinical RSV susceptible cotton rat challenge model compared to formaldehyde inactivated RSV (FI-RSV) and live RSV experimental infection. The adjuvanted G protein vaccine induced robust neutraliza...

2012
Claire-Anne Siegrist Christian van Delden Michael Bel Christophe Combescure Cécile Delhumeau Matthias Cavassini Olivier Clerc Sara Meier Karine Hadaya Paola M. Soccal Sabine Yerly Laurent Kaiser Bernard Hirschel Alexandra Calmy

BACKGROUND Memory responses require immune competence. We assessed the influence of priming with AS03-adjuvanted pandemic vaccine (Pandemrix®) on memory responses of HIV patients, kidney recipients (SOT) and healthy controls (HC). METHOD Participants (HIV: 197, SOT: 53; HC: 156) were enrolled in a prospective study and 390/406 (96%) completed it. All had been primed in 2009/2010 with 1 (HC) o...

2015
Sina Brückner Selidji T. Agnandji Stefan Berberich Emmanuel Bache José F. Fernandes Brunhilde Schweiger Marguerite Massinga Loembe Thomas Engleitner Bertrand Lell Benjamin Mordmüller Ayola A. Adegnika Maria Yazdanbakhsh Peter G. Kremsner Meral Esen Gary L. Simon

BACKGROUND Helminth infections are a major public health problem, especially in the tropics. Infected individuals have an altered immune response with evidence that antibody response to vaccination is impaired. Hence, treatment of helminth infections before vaccination may be a simple intervention to improve vaccine immunogenicity. In the present study we investigated whether a single-dose anti...

Journal: :American journal of nephrology 2012
Kelly A Birdwell Mine R Ikizler Li Wang Daniel W Byrne Edith C Sannella Peter F Wright T Alp Ikizler

BACKGROUND/AIMS Although annual influenza vaccination is recommended for kidney transplant recipients, efficacy as reflected by serum antibody titers has not been well studied beyond 1 month in kidney transplant recipients. METHODS We performed a single-center prospective cohort study of 51 kidney transplant recipients and 102 healthy controls receiving the 2006-2007 influenza vaccine. Anti-h...

Journal: :Journal of clinical microbiology 2002
Masae Itoh Yoshinobu Okuno Hak Hotta

The anti-measles virus (MV) antibody titers in the sera of vaccinees and naturally infected individuals of different age groups were measured to help assess the efficacy of the current MV vaccination in Japan. Neutralizing (NT) antibody titers induced by vaccination were 2(3.2) times lower than those induced by natural infection and declined significantly by age 20. The once-decreased NT antibo...

2015
Aldiouma Diallo Samba O. Sow Olubukola T. Idoko Siddhivinayak Hirve Helen Findlow Marie-Pierre Preziosi Cheryl Elie Prasad S. Kulkarni Varsha Parulekar Bou Diarra Fadima Cheick Haidara Fatoumata Diallo Milagritos Tapia Adebayo K. Akinsola Richard A. Adegbola Ashish Bavdekar Sanjay Juvekar Julie Chaumont Lionel Martellet Elisa Marchetti Marc F. LaForce Brian D. Plikaytis Godwin C. Enwere Yuxiao Tang Ray Borrow George Carlone Simonetta Viviani

BACKGROUND Mass vaccination campaigns of the population aged 1-29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in African meningitis belt countries has resulted in the near-disappearance of MenA. The vaccine was tested in clinical trials in Africa and in India and found to be safe and highly immunogenic compared with the group A component of the licen...

2014
Mark J. Mulligan David I. Bernstein Sharon Frey Patricia Winokur Nadine Rouphael Michelle Dickey Srilatha Edupuganti Paul Spearman Edwin Anderson Irene Graham Diana L. Noah Brian Mangal Sonnie Kim Heather Hill Jenifer Whitaker William Emery Allison Beck Kathy Stephens Brooke Hartwell Melinda Ogilvie Nayoka Rimann Eileen Osinski Ellen Destefano Theda Gajadhar Amanda Strudwick Karen Pierce Lilin Lai Ling Yue Dongli Wang Carl Ying Amy Cline Tara Foltz Nancy Wagner Geraldine Dull Thomas Pacatte Barbara Taggart Valerie Johnson Logan Haller Candi Looney Shixiong Li Megan May Bridgette Myers Rachel May Lawanda Parker Nertaissa Cochran Donna Bowen Michelle Bell Jeffery Scoggins Angela Burns Claire Stablein Mark Wolff Bernadette Jolles Brenda Leung Linda Lambert Shy Shorer Wendy Buchanan Suzanne Murray Soju Chang Richard Gorman

BACKGROUND Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs. METHODS A multicenter, randomized, blinded phase 1 clinical trial evaluated safety and antibody responses after point-of-use mixing of influenza A/Indonesia/05/200...

Journal: :Open Forum Infectious Diseases 2022

Abstract Background COVID-19 continues to cause substantial morbidity and mortality globally. It is likely that booster vaccinations will be needed in future years protect older adults those with chronic medical conditions. We present interim topline results of a phase 1/2 study IVX-411 [ACTRN12621000738820.; ACTRN12621000882820], an investigational VLP protein subunit SARS-CoV-2 vaccine, aged ...

Journal: :Journal of virology 2013
Crystal L Loving Kelly M Lager Amy L Vincent Susan L Brockmeier Phillip C Gauger Tavis K Anderson Pravina Kitikoon Daniel R Perez Marcus E Kehrli

Vaccines provide a primary means to limit disease but may not be effective at blocking infection and pathogen transmission. The objective of the present study was to evaluate the efficacy of commercial inactivated swine influenza A virus (IAV) vaccines and experimental live attenuated influenza virus (LAIV) vaccines against infection with H3N2 virus and subsequent indirect transmission to naive...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید